BDBM802060 tert-butyl (S)-8-((2S,4R)-4- hydroxy-2-(((S)-1-(4-(4-meth- ylthiazol-5-yl)phenyl)ethyl)- carbamoyl)pyrrolidine-1- carbon-yl)-7,7-dimethyl-7,8- dihydro-4H-[1,2,3]triazolo [1,5-a][1,4]diazepine-5(6H)- carboxylate::US20260108613, Compound A4

SMILES Cc1ncsc1c5ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]4n3nncc3CN(C(=O)OC(C)(C)C)CC4(C)C)cc5

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 802060   

Targetvon Hippel-Lindau disease tumor suppressor(Human)
University of Michigan

US Patent
LigandChemical structure of BindingDB Monomer ID 802060BDBM802060(tert-butyl (S)-8-((2S,4R)-4- hydroxy-2-(((S)-1-(4-...)
Affinity DataIC50: 7.5nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent